Biotechnology Assets S.A. (BST) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.00x

Biotechnology Assets S.A. (BST) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €1.99K (capex €1.99K ) from operating cash flow of €658.13K. Explore Biotechnology Assets S.A. (BST) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

€1.99K
Capex + Investments

Operating Cash Flow

€658.13K
EUR

Capital Expenditures

€1.99K
EUR

Biotechnology Assets S.A. Cash Flow Reinvestment Rate (2015–2023)

Historical reinvestment intensity for Biotechnology Assets S.A. across 5 annual periods. Also explore balance sheet size of Biotechnology Assets S.A. for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Biotechnology Assets S.A. (2015–2023)

Year-by-year capital reinvestment analysis for Biotechnology Assets S.A.. For live market cap and broader valuation context, see Biotechnology Assets S.A. market capitalisation.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2023 6.83x €325.97K €47.74K €325.97K ▲ +15235.3%
2020 0.04x €391.53K €8.79 Million €391.53K ▼ -99.4%
2017 7.33x €1.56 Million €213.49K €1.56 Million ▲ +508.5%
2016 1.20x €3.27 Million €2.71 Million €3.27 Million ▼ -82.2%
2015 6.75x €1.07 Million €158.16K €1.07 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow